Evidence map›Paper›PMID 41540779›Full record

GuidelineThe Australian and New Zealand journal of psychiatry2026

Shuichi Suetani, Frances Dark, Susanna Every-Palmer, Cherrie Galletly, Brian O'Donoghue, Sean Halstead, Dolores Keating, Nicole Korman, Julia Lappin, Sharon Lawn and 3 more

Abstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in The Australian and New Zealand journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shuichi SuetaniQueensland Centre for Mental Health Research, The University of Queensland, Wacol, QLD, Australia.ORCID 0000-0002-2487-5691
Frances DarkMetro South Addiction and Mental Health Service, Metro South Health, Brisbane, QLD, Australia.ORCID 0000-0002-8776-207X
Susanna Every-PalmerDepartment of Psychological Medicine, University of Otago, Wellington, New Zealand.ORCID 0000-0001-6455-9741
Cherrie GalletlyNorthern Adelaide Local Health Network, SA Health, Adelaide, SA, Australia.
Brian O'DonoghueSchool of Medicine, University College Dublin, Dublin, Ireland.ORCID 0000-0001-6240-6952
Sean HalsteadQueensland Centre for Mental Health Research, The University of Queensland, Wacol, QLD, Australia.ORCID 0009-0000-4890-3506
Dolores KeatingPharmacy Services, St John of God University Hospital, Dublin, Ireland.ORCID 0000-0001-7507-2680
Nicole KormanQueensland Centre for Mental Health Research, The University of Queensland, Wacol, QLD, Australia.
Julia LappinDiscipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, Australia.ORCID 0000-0001-5946-2144
Sharon LawnLived Experience Australia Ltd, Adelaide, SA, Australia.
Andrew ThompsonOrygen, Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia.
Nicola WarrenQueensland Centre for Mental Health Research, The University of Queensland, Wacol, QLD, Australia.ORCID 0000-0002-0805-1182
Dan SiskindQueensland Centre for Mental Health Research, The University of Queensland, Wacol, QLD, Australia.ORCID 0000-0002-2072-9216

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe current Guidelines aim to provide evidence-based management recommendations for treatment of people living with schizophrenia in Australia and Aotearoa New Zealand.

methodsThe

resultsThe ANZJP GRADE Guidelines examined the current evidence base for a range of areas relevant to treatment for people with schizophrenia including: initial physical health assessment; pharmacological treatment; psychological and psychosocial interventions; family, whānau and carers; psychiatric comorbidities; physical health and lifestyle interventions; and special populations.

conclusionsIt is hoped that the current Guidelines provide useful recommendations in important aspects of care for people living with schizophrenia and their family, whānau and carers in Australia and Aotearoa New Zealand, both at the individual and systemic levels.

Indexed as

Evidence-Based MedicinePractice Guidelines as TopicSchizophreniaAustraliaHumansNew ZealandGRADEguidelinesSchizophrenia

Identifiers

PMID41540779
PMCPMC13000005

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.